Selected research
Industry Research
Plasma Albumin Industry Research Report 2026
Market perspective
The global Plasma Albumin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Plasma Albumin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Plasma Albumin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Plasma Albumin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Plasma Albumin include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shanghai RAAS, Hualan Bio, Shuanglin Bio, Octapharma and LFB Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Plasma Albumin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Albumin Market by Company
Yuanda Shuyang
Takeda
Weiguang Bio
Tiantan Bio
Shanghai RAAS
Hualan Bio
Shuanglin Bio
Octapharma
LFB Group
Kedrion
Grifols
CSL
CBPO
Boya Bio
Biotest
Plasma Albumin Segment by Type
20-25% Concentrations
5% Concentrations
Plasma Albumin Segment by Application
Therapeutics
Excipient
Other
Plasma Albumin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Plasma Albumin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Plasma Albumin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Plasma Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20-25% Concentrations
- 5% Concentrations
Applications
- Therapeutics
- Excipient
- Other
Companies covered
- Yuanda Shuyang
- Takeda
- Weiguang Bio
- Tiantan Bio
- Shanghai RAAS
- Hualan Bio
- Shuanglin Bio
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CBPO
- Boya Bio
- Biotest
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Plasma Albumin Market Size (2021-2032)
- 2.2.2 Global Plasma Albumin Sales (2021-2032)
- 2.2.3 Global Plasma Albumin Market Average Price (2021-2032)
- 2.3 Plasma Albumin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20-25% Concentrations
- 2.3.3 5% Concentrations
- 2.4 Plasma Albumin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Therapeutics
- 2.4.3 Excipient
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Plasma Albumin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Plasma Albumin Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Plasma Albumin Revenue of Manufacturers (2021-2026)
- 3.4 Global Plasma Albumin Average Price by Manufacturers (2021-2026)
- 3.5 Global Plasma Albumin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Plasma Albumin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Plasma Albumin, Product Type & Application
- 3.8 Global Manufacturers of Plasma Albumin, Established Date
- 3.9 Global Plasma Albumin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yuanda Shuyang
- 4.1.1 Yuanda Shuyang Company Information
- 4.1.2 Yuanda Shuyang Business Overview
- 4.1.3 Yuanda Shuyang Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yuanda Shuyang Plasma Albumin Product Portfolio
- 4.1.5 Yuanda Shuyang Recent Developments
- 4.2 Takeda
- 4.2.1 Takeda Company Information
- 4.2.2 Takeda Business Overview
- 4.2.3 Takeda Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Plasma Albumin Product Portfolio
- 4.2.5 Takeda Recent Developments
- 4.3 Weiguang Bio
- 4.3.1 Weiguang Bio Company Information
- 4.3.2 Weiguang Bio Business Overview
- 4.3.3 Weiguang Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Weiguang Bio Plasma Albumin Product Portfolio
- 4.3.5 Weiguang Bio Recent Developments
- 4.4 Tiantan Bio
- 4.4.1 Tiantan Bio Company Information
- 4.4.2 Tiantan Bio Business Overview
- 4.4.3 Tiantan Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tiantan Bio Plasma Albumin Product Portfolio
- 4.4.5 Tiantan Bio Recent Developments
- 4.5 Shanghai RAAS
- 4.5.1 Shanghai RAAS Company Information
- 4.5.2 Shanghai RAAS Business Overview
- 4.5.3 Shanghai RAAS Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai RAAS Plasma Albumin Product Portfolio
- 4.5.5 Shanghai RAAS Recent Developments
- 4.6 Hualan Bio
- 4.6.1 Hualan Bio Company Information
- 4.6.2 Hualan Bio Business Overview
- 4.6.3 Hualan Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hualan Bio Plasma Albumin Product Portfolio
- 4.6.5 Hualan Bio Recent Developments
- 4.7 Shuanglin Bio
- 4.7.1 Shuanglin Bio Company Information
- 4.7.2 Shuanglin Bio Business Overview
- 4.7.3 Shuanglin Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shuanglin Bio Plasma Albumin Product Portfolio
- 4.7.5 Shuanglin Bio Recent Developments
- 4.8 Octapharma
- 4.8.1 Octapharma Company Information
- 4.8.2 Octapharma Business Overview
- 4.8.3 Octapharma Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Octapharma Plasma Albumin Product Portfolio
- 4.8.5 Octapharma Recent Developments
- 4.9 LFB Group
- 4.9.1 LFB Group Company Information
- 4.9.2 LFB Group Business Overview
- 4.9.3 LFB Group Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LFB Group Plasma Albumin Product Portfolio
- 4.9.5 LFB Group Recent Developments
- 4.10 Kedrion
- 4.10.1 Kedrion Company Information
- 4.10.2 Kedrion Business Overview
- 4.10.3 Kedrion Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kedrion Plasma Albumin Product Portfolio
- 4.10.5 Kedrion Recent Developments
- 4.11 Grifols
- 4.11.1 Grifols Company Information
- 4.11.2 Grifols Business Overview
- 4.11.3 Grifols Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Grifols Plasma Albumin Product Portfolio
- 4.11.5 Grifols Recent Developments
- 4.12 CSL
- 4.12.1 CSL Company Information
- 4.12.2 CSL Business Overview
- 4.12.3 CSL Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CSL Plasma Albumin Product Portfolio
- 4.12.5 CSL Recent Developments
- 4.13 CBPO
- 4.13.1 CBPO Company Information
- 4.13.2 CBPO Business Overview
- 4.13.3 CBPO Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CBPO Plasma Albumin Product Portfolio
- 4.13.5 CBPO Recent Developments
- 4.14 Boya Bio
- 4.14.1 Boya Bio Company Information
- 4.14.2 Boya Bio Business Overview
- 4.14.3 Boya Bio Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Boya Bio Plasma Albumin Product Portfolio
- 4.14.5 Boya Bio Recent Developments
- 4.15 Biotest
- 4.15.1 Biotest Company Information
- 4.15.2 Biotest Business Overview
- 4.15.3 Biotest Plasma Albumin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Biotest Plasma Albumin Product Portfolio
- 4.15.5 Biotest Recent Developments
5 Global Plasma Albumin Market Scenario by Region
- 5.1 Global Plasma Albumin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Plasma Albumin Sales by Region: 2021-2032
- 5.2.1 Global Plasma Albumin Sales by Region: 2021-2026
- 5.2.2 Global Plasma Albumin Sales by Region: 2027-2032
- 5.3 Global Plasma Albumin Revenue by Region: 2021-2032
- 5.3.1 Global Plasma Albumin Revenue by Region: 2021-2026
- 5.3.2 Global Plasma Albumin Revenue by Region: 2027-2032
- 5.4 North America Plasma Albumin Market Facts & Figures by Country
- 5.4.1 North America Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Plasma Albumin Sales by Country (2021-2032)
- 5.4.3 North America Plasma Albumin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Plasma Albumin Market Facts & Figures by Country
- 5.5.1 Europe Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Plasma Albumin Sales by Country (2021-2032)
- 5.5.3 Europe Plasma Albumin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Plasma Albumin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Plasma Albumin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Plasma Albumin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Plasma Albumin Market Facts & Figures by Country
- 5.7.1 South America Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Plasma Albumin Sales by Country (2021-2032)
- 5.7.3 South America Plasma Albumin Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Plasma Albumin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Plasma Albumin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Plasma Albumin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Plasma Albumin Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Plasma Albumin Sales by Type (2021-2032)
- 6.1.1 Global Plasma Albumin Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Plasma Albumin Sales Market Share by Type (2021-2032)
- 6.2 Global Plasma Albumin Revenue by Type (2021-2032)
- 6.2.1 Global Plasma Albumin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Plasma Albumin Revenue Market Share by Type (2021-2032)
- 6.3 Global Plasma Albumin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Plasma Albumin Sales by Application (2021-2032)
- 7.1.1 Global Plasma Albumin Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Plasma Albumin Sales Market Share by Application (2021-2032)
- 7.2 Global Plasma Albumin Revenue by Application (2021-2032)
- 7.2.1 Global Plasma Albumin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Plasma Albumin Revenue Market Share by Application (2021-2032)
- 7.3 Global Plasma Albumin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Plasma Albumin Value Chain Analysis
- 8.1.1 Plasma Albumin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Plasma Albumin Production Mode & Process
- 8.2 Plasma Albumin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Plasma Albumin Distributors
- 8.2.3 Plasma Albumin Customers
9 Global Plasma Albumin Analyzing Market Dynamics
- 9.1 Plasma Albumin Industry Trends
- 9.2 Plasma Albumin Industry Drivers
- 9.3 Plasma Albumin Industry Opportunities and Challenges
- 9.4 Plasma Albumin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst